Cognetivity Neurosciences (STU:1UB) Net Margin %: -7,035.00% (As of Oct. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cognetivity Neurosciences Net Margin %?

Cognetivity Neurosciences STU:1UB Net Margin % is -7,035.00% as of Oct. 2023.

Net margin is calculated as Net Income divided by its Revenue. Cognetivity Neurosciences's Net Income for the three months ended in Oct. 2023 was €-1.41 Mil. Cognetivity Neurosciences's Revenue for the three months ended in Oct. 2023 was €0.02 Mil. Therefore, Cognetivity Neurosciences's net margin for the quarter that ended in Oct. 2023 was -7,035.00%.

The historical rank and industry rank for Cognetivity Neurosciences's Net Margin % or its related term are showing as below:


STU:1UB's Net Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.92
* Ranked among companies with meaningful Net Margin % only.

Cognetivity Neurosciences  (STU:1UB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Cognetivity Neurosciences Net Margin % Related Terms

Cognetivity Neurosciences Net Margin % Historical Data

* Premium members only.

The historical data trend for Cognetivity Neurosciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cognetivity Neurosciences Net Margin % Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Net Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -16,580.65

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -5,719.35 -47,500.00 -9,457.14 -7,035.00

STU:1UB vs VEEV, GEHC, HQY: Net Margin % Comparison

For the Health Information Services subindustry, Cognetivity Neurosciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cognetivity Neurosciences Net Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Net Margin % falls into.


Cognetivity Neurosciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Cognetivity Neurosciences's Net Margin for the fiscal year that ended in Jan. 2023 is calculated as

Net Margin=Net Income (A: Jan. 2023 )/Revenue (A: Jan. 2023 )
=-5.14/0.031
=-16,580.65 %

Cognetivity Neurosciences's Net Margin for the quarter that ended in Oct. 2023 is calculated as

Net Margin=Net Income (Q: Oct. 2023 )/Revenue (Q: Oct. 2023 )
=-1.407/0.02
=-7,035.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -7,035.00% mean?
Cognetivity Neurosciences (STU:1UB) has a Net Margin % of -7,035.00% as of Oct. 2023. Net margin is the ratio of total net income to net sales. View historical data on Cognetivity Neurosciences and its competitors.
Is Cognetivity Neurosciences' Net Margin % too high?
Cognetivity Neurosciences' current Net Margin % is -7,035.00%.
How does Cognetivity Neurosciences' Net Margin % compare to VEEV and GEHC?
Cognetivity Neurosciences' Net Margin % of -7,035.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median Net Margin % is 2.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Cognetivity Neurosciences and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cognetivity Neurosciences's current Net Margin % is -7,035.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cognetivity Neurosciences stock overvalued right now?
Cognetivity Neurosciences (STU:1UB) has a current Net Margin % of -7,035.00%. The current Net Margin % is -7,035.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Cognetivity Neurosciences (STU:1UB), the current Net Margin % is -7,035.00% as of Oct. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cognetivity Neurosciences Business Description

Address 800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.